ERBB2 and triple-negative breast carcinoma: Stratified survival analysis showed significant differences in survival between high- and low-risk groups with different T subgroups, stage subgroups, age (age >30), and subtypes (HER2-enriched, LuminalA, LuminalB, and triple negative breast cancer (TNBC)) in the training set (Figures 3A–I).